ZURICH, Sept 15 (Reuters) - Symetis, a Swiss maker of replacement heart valves, hopes to grab market share with its products offering less invasive procedures without open-heart surgery, it said on Tuesday as it launched an 80 million Swiss franc ($83 million) stock sale.
Symetis is selling up to 2.3 million new shares in an initial public offering (IPO) priced at between 35 and 46 francs, implying a market value for the company of between 200 million francs and 240 million.
Help employers find you! Check out all the jobs and post your resume.
Symetis is selling up to 2.3 million new shares in an initial public offering (IPO) priced at between 35 and 46 francs, implying a market value for the company of between 200 million francs and 240 million.
Help employers find you! Check out all the jobs and post your resume.
